These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38623388)

  • 41. Acute Kidney Injury in COVID-19 Patients: An Inner City Hospital Experience and Policy Implications.
    Zahid U; Ramachandran P; Spitalewitz S; Alasadi L; Chakraborti A; Azhar M; Mikhalina G; Sherazi A; Narh JT; Khattar P; Bedi P
    Am J Nephrol; 2020; 51(10):786-796. PubMed ID: 33011717
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Study of Acute Kidney Injury on 309 Hypertensive Inpatients with ACEI/ARB - Diuretic Treatment.
    Chen Q; Zhu S; Liao J; He W
    J Natl Med Assoc; 2018 Jun; 110(3):287-296. PubMed ID: 29778133
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development and Validation of a Risk Model for Predicting Contrast-Associated Acute Kidney Injury in Patients With Cancer: Evaluation in Over 46,000 CT Examinations.
    Gupta S; Motwani SS; Seitter RH; Wang W; Mu Y; Chute DF; Sise ME; Glazer DI; Rosner BA; Curhan GC
    AJR Am J Roentgenol; 2023 Oct; 221(4):486-501. PubMed ID: 37195792
    [No Abstract]   [Full Text] [Related]  

  • 44. A comprehensive analysis of intraoperative factors associated with acute-on-chronic kidney injury in elderly trauma patients: blood loss as a key predictor.
    Lisitano L; Röttinger T; Thorne T; Förch S; Cifuentes J; Rau K; Vounatsos PD; Mayr E
    Aging Clin Exp Res; 2023 Nov; 35(11):2729-2737. PubMed ID: 37646924
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care.
    Bidulka P; Fu EL; Leyrat C; Kalogirou F; McAllister KSL; Kingdon EJ; Mansfield KE; Iwagami M; Smeeth L; Clase CM; Bhaskaran K; van Diepen M; Carrero JJ; Nitsch D; Tomlinson LA
    BMC Med; 2020 Jul; 18(1):195. PubMed ID: 32723383
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Morbidity and mortality of acute renal failure in the Critical Care Unit of a regional hospital.
    Esteban Ciriano ME; Peña Porta JM; Vicente de Vera Floristán C; Olagorta García S; Álvarez Lipe R; Vicente de Vera Floristán JM
    Rev Esp Anestesiol Reanim (Engl Ed); 2018; 65(6):314-322. PubMed ID: 29598959
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessing Discharge Communication and Follow-up of Acute Kidney Injury in British Columbia: A Retrospective Chart Review.
    Birks P; Al-Zeer B; Holmes D; Elzayat R; Canney M; Djurdjev O; Shao TS; Zheng Y; Silver SA; Levin A
    Can J Kidney Health Dis; 2024; 11():20543581231222064. PubMed ID: 38322506
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of hospital-acquired acute kidney injury on Covid-19 outcomes in patients with and without chronic kidney disease: a multicenter retrospective cohort study.
    Öztürk S; Turgutalp K; Arıcı M; Çetinkaya H; Altıparmak MR; Aydın Z; Soypaçacı Z; Bora F; Kara E; Cebeci E; Özler TE; Dölarslan ME; Sipahi S; Ayar Y; Şahin İ; Bakırdöğen S; İslam M; Görgülü N; Öğütmen MB; Şengül E; Güngör Ö; Seyahi N; Tokgöz B; Odabaş AR; Tonbul HZ; Sezer S; Yıldız A; Ateş K
    Turk J Med Sci; 2021 Jun; 51(3):947-961. PubMed ID: 33611868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment patterns of patients with acute heart failure who develop acute kidney injury.
    Boulos J; Darawsha W; Abassi ZA; Azzam ZS; Aronson D
    ESC Heart Fail; 2019 Feb; 6(1):45-52. PubMed ID: 30569598
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Acute Kidney Disease after an Episode of AKI: A Multicenter Prospective Cohort Study.
    Hines A; Li X; Ortiz-Soriano V; Saleh S; Litteral J; Ruiz-Conejo M; Wald R; Silver SA; Neyra JA
    Am J Nephrol; 2020; 51(4):266-275. PubMed ID: 32088714
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
    Sharma P; Blackburn RC; Parke CL; McCullough K; Marks A; Black C
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007751. PubMed ID: 21975774
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute Kidney Injury Recovery Pattern and Subsequent Risk of CKD: An Analysis of Veterans Health Administration Data.
    Heung M; Steffick DE; Zivin K; Gillespie BW; Banerjee T; Hsu CY; Powe NR; Pavkov ME; Williams DE; Saran R; Shahinian VB;
    Am J Kidney Dis; 2016 May; 67(5):742-52. PubMed ID: 26690912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
    Fang G; Annis IE; Farley JF; Mahendraratnam N; Hickson RP; Stürmer T; Robinson JG
    Pharmacotherapy; 2018 Jan; 38(1):29-41. PubMed ID: 29059475
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute kidney injury: outcomes and quality of care.
    Aitken E; Carruthers C; Gall L; Kerr L; Geddes C; Kingsmore D
    QJM; 2013 Apr; 106(4):323-32. PubMed ID: 23345468
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute kidney injury associated with COVID-19: A retrospective cohort study.
    Kolhe NV; Fluck RJ; Selby NM; Taal MW
    PLoS Med; 2020 Oct; 17(10):e1003406. PubMed ID: 33125416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hospitalisation Due to Community-Acquired Acute Kidney Injury and the Role of Medications: A Retrospective Audit.
    Duong H; Tesfaye W; Van C; Sud K; Castelino RL
    J Clin Med; 2023 May; 12(9):. PubMed ID: 37176787
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prospective Cohort Study of Renin-Angiotensin System Blocker Usage after Hospitalized Acute Kidney Injury.
    Brar S; Liu KD; Go AS; Hsu RK; Chinchilli VM; Coca SG; Garg AX; Himmelfarb J; Ikizler TA; Kaufman J; Kimmel PL; Parikh CR; Siew ED; Ware LB; Zeng H; Hsu CY; ;
    Clin J Am Soc Nephrol; 2020 Dec; 16(1):26-36. PubMed ID: 33272913
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    Pei Y; Miu M; Mao X; Chen W; Zhu J
    Int J Clin Pract; 2023; 2023():8244545. PubMed ID: 38187354
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute Kidney Injury in Patients Continued on Renin-Angiotensin System Blockers During Hospitalization.
    Alabdan N; Gosmanova EO; Tran NQ; Oliphant CS; Pan H; Broyles JE; Hudson JQ
    Am J Med Sci; 2017 Feb; 353(2):172-177. PubMed ID: 28183419
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The association between dual RAAS inhibition and risk of acute kidney injury and hyperkalemia in patients with diabetic kidney disease: a systematic review and meta-analysis.
    Whitlock R; Leon SJ; Manacsa H; Askin N; Rigatto C; Fatoba ST; Farag YMK; Tangri N
    Nephrol Dial Transplant; 2023 Oct; 38(11):2503-2516. PubMed ID: 37309038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.